文献速递心律失常

早期节律控制治疗中房颤患者的心率分析

Heart rate in early rhythm control therapy in patients with atrial fibrillation.
PubMed 文献 · Heart · 2026-02-09

该研究基于EAST-AFNET 4试验,分析基线房颤心率<110次/分与≥110次/分的患者,发现高心率与更严重症状相关,但心血管复合终点事件率无差异,早期节律控制均能减少事件。

要点

  • 基线房颤心率≥110次/分者症状更重,但心血管事件率与<110次/分者无差异。
  • 早期节律控制在高心率和低心率房颤患者中均减少不良结局。
  • 房颤心率与心血管并发症的关系需结合症状评估,而非仅看心率数值。

核心结论

  • 房颤时高心率(≥110次/分)与更多且更严重的房颤相关症状相关,但心血管事件率在心率<110次/分与≥110次/分患者间无差异。
  • 早期节律控制在高心率和低心率房颤患者中均减少结局事件。

研究设计与样本

  • EAST-AFNET 4试验的事后分析,比较基线房颤心率<110次/分与≥110次/分患者的症状、治疗策略及心血管复合终点。
  • 基线房颤且有心率信息的患者共772例,平均年龄70.8±7.8岁,女性305例(40%),随机分配至早期节律控制385例(50%),心率<110次/分者506例(66%)。

主要发现

  • 基线心率≥110次/分者症状性房颤比例更高(78% vs 62%,p<0.001),EHRA评分≥3的严重症状比例更高(19% vs 12%,p=0.032)。
  • 主要复合终点(心血管死亡、卒中或心衰恶化/急性冠脉综合征住院)在心率<110次/分组发生116例(5.1/100人年),≥110次/分组发生62例(5.1/100人年)。
  • 心率≥110次/分 compared with <110次/分的主要终点HR为1.08(95%CI 0.79-1.48)。

临床怎么用

  • 房颤患者心率≥110次/分提示症状负担更重,应积极评估症状并考虑节律控制。
  • 早期节律控制策略在高心率和低心率患者中均带来获益,不应仅因心率不高而延迟节律控制。

局限性

  • 该分析为EAST-AFNET 4试验的事后分析,结果需谨慎解读。
  • 仅纳入基线房颤且有心率信息的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preventing high heart rates in atrial fibrillation (AF) is recommended to reduce AF-related symptoms and morbidity. Evidence on a strong relationship between lower heart rate during AF and a reduction in symptoms or cardiovascular complications is, however, lacking. METHODS: This Early Treatment of Atrial Fibrillation for Stroke Prevention Trial analysis compared symptoms, treatment strategy and the composite of death from cardiovascular causes, stroke or hospitalisation with worsening of heart failure or acute coronary syndrome between patients with a heart rate <110 beats per minute and ≥110 beats per minute at baseline. RESULTS: At baseline, 772 patients were in AF and had information on heart rate available. Mean age was 70.8±7.8 years, 305 (40%) were women, 385 (50%) were randomised to early rhythm control and 506 (66%) patients had a heart rate <110 beats per minute. Patients with a heart rate ≥110 beats per minute at baseline were more likely to have symptomatic AF (78% vs 62%, p<0.001) and more likely to have severe symptomatic AF with a European Heart Rhythm Association score ≥3 (19% vs 12%, p=0.032). The primary outcome, a composite of death from cardiovascular causes, stroke or hospitalisation with worsening of heart failure or acute coronary syndrome, occurred in 116 patients with a heart rate <110 beats per minute (5.1 per 100 person-years) and 62 patients with a heart rate ≥110 beats per minute (5.1 per 100 person years). The HR of the primary outcome for patients with a heart rate ≥110 beats per minute compared with patients with a heart rate <110 beats per minute was 1.08 (95% CI 0.79 to 1.48). CONCLUSION: A high heart rate (≥110 beats per minute) during AF is associated with more and more severe AF-related symptoms. Cardiovascular event rates are not different between heart rates. Early rhythm control reduces outcomes in patients with high and low heart rates during AF. TRIAL REGISTRATION NUMBER: NCT01288352.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Koldenhof, Borof, Van Gelder, et al. Heart rate in early rhythm control therapy in patients with atrial fibrillation. Heart. 2026. PMID: 41663267. doi:10.1136/heartjnl-2025-326878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。